Testosterone Replacement In Prostate Cancer Remission | Mark Scholz MD | Alex Scholz | PCRI

Medical Oncologist Mark Scholz, MD gives a survey of testosterone replacement therapy (TRT) in the context of prostate cancer. Historically, some in the medical community have been hesitant to consider testosterone in patients with a history of prostate cancer out of fear of exacerbating the disease. However, for men in remission or on intermittent hormone therapy, testosterone is expected or assumed to return naturally; thus, there is no reason to assume that medically-supervised administration of TRT in a man whose testosterone does not recover naturally would have any unique prostate cancer risks that are not already assumed when a man discontinues hormone therapy.

0:06 What is testosterone replacement therapy (TRT)?

1:42 Does testosterone cause or grow prostate cancer?

3:48 What are the side effects of TRT?

4:56 Is it possible to build muscle while on hormone therapy for prostate cancer?

7:01 Can you explain the process of using TRT after hormone therapy for prostate cancer in men whose testosterone does not recover naturally?

9:01 How do you monitor whether a man's testosterone is recovering and whether it is safe to do TRT if it is not recovering naturally?

10:51 How much of a buffer is needed between the end of hormone therapy and when you would consider beginning TRT if a man's testosterone does not recover?

11:37 How does dosing work with TRT?

13:19 What is the difference between potency and libido and how is it relevant in this context?

14:37 Should all patients on hormone therapy be checking their testosterone to be sure that the therapy is working?

15:24 How do you monitor patients on TRT after hormone therapy? Are there any notable risks that you monitor for?

_

Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org

To learn more about prostate cancer visit http://www.pcri.org

Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

Previous
Previous

U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA® (Flotufolastat F 18) Injection First Radiohybrid PSMA‐targeted PET Imaging Agent for Prostate Cancer

Next
Next

Testosterone Replacement Therapy For Metastatic Prostate Cancer | Mark Scholz MD | Alex Scholz | PCRI